IRD ▲ +2.0% - Opus Genetics, Inc. $IRD - Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness 21-OCT-2026 07:00 AM ET